Email this article to a friend
Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
-
* Corresponding author: Darren M Ashcroft darren.ashcroft@manchester.ac.uk
Arthritis Research & Therapy 2009, 11:R52 doi:10.1186/ar2670
See related editorial by Aletaha et al., http://arthritis-research.com/content/11/3/112